Mingchen Health Co.,Ltd. (SHE:002919)
15.37
-0.25 (-1.60%)
May 9, 2025, 2:45 PM CST
Mingchen Health Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,380 | 1,634 | 944.04 | 743.07 | 677.12 | Upgrade
|
Other Revenue | - | 3.38 | 1.37 | 1.08 | 3.45 | Upgrade
|
Revenue | 1,380 | 1,638 | 945.4 | 744.15 | 680.57 | Upgrade
|
Revenue Growth (YoY) | -15.71% | 73.21% | 27.05% | 9.34% | 31.52% | Upgrade
|
Cost of Revenue | 655.62 | 660.08 | 457.7 | 378.28 | 407.98 | Upgrade
|
Gross Profit | 724.63 | 977.49 | 487.71 | 365.87 | 272.59 | Upgrade
|
Selling, General & Admin | 549.66 | 772.95 | 400.32 | 152.59 | 124.6 | Upgrade
|
Research & Development | 69.41 | 111.27 | 110.26 | 98.51 | 46.27 | Upgrade
|
Other Operating Expenses | 4.95 | 4.71 | 5.36 | 6.57 | 6.35 | Upgrade
|
Operating Expenses | 624.03 | 903.25 | 507.77 | 264.18 | 178.28 | Upgrade
|
Operating Income | 100.6 | 74.24 | -20.06 | 101.69 | 94.31 | Upgrade
|
Interest Expense | - | -3.68 | -1.95 | -1.71 | -2.16 | Upgrade
|
Interest & Investment Income | 0.15 | 1.15 | 6.76 | 25.21 | 9.29 | Upgrade
|
Currency Exchange Gain (Loss) | - | 1.76 | 0.99 | - | - | Upgrade
|
Other Non Operating Income (Expenses) | -53.62 | 0.69 | -1.28 | -2.5 | -0.14 | Upgrade
|
EBT Excluding Unusual Items | 47.14 | 74.16 | -15.54 | 122.69 | 101.3 | Upgrade
|
Impairment of Goodwill | - | -23.54 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | 0.38 | - | -0 | 0 | 0.55 | Upgrade
|
Gain (Loss) on Sale of Assets | 4.38 | 2.07 | 0.1 | -0.01 | - | Upgrade
|
Asset Writedown | -24.42 | -0.02 | -0.05 | -0.12 | -0.63 | Upgrade
|
Other Unusual Items | - | 3.97 | 30.75 | 4.94 | 3.54 | Upgrade
|
Pretax Income | 27.48 | 56.63 | 15.25 | 127.51 | 104.76 | Upgrade
|
Income Tax Expense | -19.24 | -13.73 | -10.14 | -5.99 | 2.52 | Upgrade
|
Earnings From Continuing Operations | 46.72 | 70.36 | 25.39 | 133.49 | 102.24 | Upgrade
|
Minority Interest in Earnings | 0 | - | - | - | - | Upgrade
|
Net Income | 46.72 | 70.36 | 25.39 | 133.49 | 102.24 | Upgrade
|
Net Income to Common | 46.72 | 70.36 | 25.39 | 133.49 | 102.24 | Upgrade
|
Net Income Growth | -33.60% | 177.15% | -80.98% | 30.57% | 343.05% | Upgrade
|
Shares Outstanding (Basic) | 260 | 264 | 277 | 267 | 266 | Upgrade
|
Shares Outstanding (Diluted) | 260 | 264 | 277 | 267 | 266 | Upgrade
|
Shares Change (YoY) | -1.62% | -4.71% | 3.70% | 0.43% | 0.22% | Upgrade
|
EPS (Basic) | 0.18 | 0.27 | 0.09 | 0.50 | 0.38 | Upgrade
|
EPS (Diluted) | 0.18 | 0.27 | 0.09 | 0.50 | 0.38 | Upgrade
|
EPS Growth | -32.51% | 190.84% | -81.66% | 30.00% | 342.07% | Upgrade
|
Free Cash Flow | 116.66 | 56.61 | -77.28 | 64.4 | 157.05 | Upgrade
|
Free Cash Flow Per Share | 0.45 | 0.21 | -0.28 | 0.24 | 0.59 | Upgrade
|
Dividend Per Share | - | 0.125 | - | 0.137 | 0.117 | Upgrade
|
Dividend Growth | - | - | - | 17.64% | 155.02% | Upgrade
|
Gross Margin | 52.50% | 59.69% | 51.59% | 49.17% | 40.05% | Upgrade
|
Operating Margin | 7.29% | 4.53% | -2.12% | 13.66% | 13.86% | Upgrade
|
Profit Margin | 3.38% | 4.30% | 2.69% | 17.94% | 15.02% | Upgrade
|
Free Cash Flow Margin | 8.45% | 3.46% | -8.18% | 8.65% | 23.08% | Upgrade
|
EBITDA | 129.28 | 218.51 | 17.11 | 119.69 | 106.75 | Upgrade
|
EBITDA Margin | 9.37% | 13.34% | 1.81% | 16.08% | 15.68% | Upgrade
|
D&A For EBITDA | 28.68 | 144.27 | 37.16 | 18.01 | 12.44 | Upgrade
|
EBIT | 100.6 | 74.24 | -20.06 | 101.69 | 94.31 | Upgrade
|
EBIT Margin | 7.29% | 4.53% | -2.12% | 13.66% | 13.86% | Upgrade
|
Effective Tax Rate | - | - | - | - | 2.41% | Upgrade
|
Revenue as Reported | - | 1,638 | 945.4 | 744.15 | 680.57 | Upgrade
|
Advertising Expenses | - | 7.07 | 4.16 | 5.61 | 5.88 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.